Here, we identified a direct interaction between PRRX1 and TOP2A, revealing a mechanism by which high PRRX1 and TOP2A expression is associated with poor prognosis in MPNST patients. The gene discussed is PRRX1; the disease is malignant peripheral nerve sheath tumor.